IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
75 hedge funds and large institutions have $68.1M invested in IVERIC bio, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 18 increasing their positions, 23 reducing their positions, and 9 closing their positions.
100% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 9
59% more call options, than puts
Call options by funds: $275K | Put options by funds: $173K
12% more funds holding
Funds holding: 67 → 75 (+8)
8% more capital invested
Capital invested by funds: $63.3M → $68.1M (+$4.76M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
22% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$2.36M |
| 2 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$2.05M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.24M |
| 4 |
Millennium Management
New York
|
+$955K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$831K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$3.2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.54M |
| 3 |
BlackRock
New York
|
-$1.54M |
| 4 |
LCM
Laurion Capital Management
New York
|
-$1.21M |
| 5 |
First Manhattan
New York
|
-$1.2M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
QIM
76
Quantitative Investment Management
Charlottesville,
Virginia
| – | -$900K | -319,300 | Closed |
|
|
DCM
77
DAFNA Capital Management
Los Angeles,
California
| – | -$141K | -50,000 | Closed |
|
|
VF
78
Virtu Financial
New York
| – | -$140K | -49,634 | Closed |
|
79
Walleye Trading
New York
| – | -$135 | -47,960 | Closed |
|
80
ProShare Advisors
Bethesda,
Maryland
| – | -$57K | -20,244 | Closed |
|
|
PCM
81
Prelude Capital Management
New York
| – | -$28K | -10,000 | Closed |
|
|
ECM
82
Estabrook Capital Management
New York
| – | -$71 | -25 | Closed |
|
|
SWP
83
Stratos Wealth Partners
Beachwood,
Ohio
| – | +$197 | +70 | New |
|
ISEE Hedge Fund Activity: Q4 2017 in Review
75 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q4 2017, worth a combined $68.1M — up 7.5% from $63.3M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new ISEE positions and 9 closed out — a net gain of 9 holders — while 18 added to existing stakes and 23 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $2.36M. The largest seller was Stonepine Capital Management, cutting an estimated $3.2M.
- 75 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q4 2017, up from 67 in Q3 2017.
- Funds reported $68.1M of IVERIC bio, Inc. Common Stock stock for Q4 2017, up 7.5% quarter-over-quarter.
- 18 funds opened new IVERIC bio, Inc. Common Stock positions in Q4 2017 and 9 closed out, a net change of +9 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q4 2017 was Morgan Stanley, an estimated $2.36M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q4 2017 was Stonepine Capital Management, an estimated $3.2M sold.
Based on aggregated 13F filings for Q4 2017.